EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Autosomal Dominant MPAN : Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes

Chloé Angelini, Christelle Marie Durand, Patricia Fergelot, Julie Deforges, Anne Vital, Patrice Menegon, Elizabeth Sarrazin, Rémi Bellance, Stéphane Mathis, Victoria Gonzalez, Mathilde Renaud, Solène Frismand und 9 weitere

Movement Disorders · 2023-11 · 38 (11) · 2103-2115

DOI: 10.1002/mds.29576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 21.08.2023. Verfasst von Chloé Angelini und 20 weiteren Autor:innen. Beteiligte Einrichtung: Service de Génétique Médicale, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Mosaicism, Movement Disorders. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence de la biomédecine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitochondrial membrane protein‐associated neurodegeneration (MPAN) is caused by mutations in the C19orf12 gene. MPAN typically appears in the first two decades of life and presents with progressive dystonia‐parkinsonism, lower motor neuron signs, optic atrophy, and abnormal iron deposits predominantly in the basal ganglia. MPAN, initially considered as a strictly autosomal recessive disease (AR), turned out to be also dominantly inherited (AD).

Objectives

Our aim was to better characterize the clinical, molecular, and functional spectra associated with such dominant pathogenic heterozygous C19orf12 variants.

Methods

We collected clinical, imaging, and molecular information of eight individuals from four AD‐MPAN families and obtained brain neuropathology results for one. Functional studies, focused on energy and iron metabolism, were conducted on fibroblasts from AD‐MPAN patients, AR‐MPAN patients, and controls.

Results

We identified four heterozygous C19orf12 variants in eight AD‐MPAN patients. Two of them carrying the familial variant in mosaic displayed an atypical late‐onset phenotype. Fibroblasts from AD‐MPAN showed more severe alterations of iron storage metabolism and autophagy compared to AR‐MPAN cells.

Conclusion

Our data add strong evidence of the realness of AD‐MPAN with identification of novel monoallelic C19orf12 variants, including at the mosaic state. This has implications in diagnosis procedures. We also expand the phenotypic spectrum of MPAN to late onset atypical presentations. Finally, we demonstrate for the first time more drastic abnormalities of iron metabolism and autophagy in AD‐MPAN than in AR‐MPAN. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MosaicismMovement DisordersHumansMitochondrial ProteinsIronMutationMembrane ProteinsPhenotype

Stichwörter der Autor:innen

C19orf12NBIAautosomal dominant MPANlate-onset MPANmosaicism

Substanzen

Mitochondrial ProteinsIronMembrane ProteinsC19orf12 protein, human

Autor:innen und Institutionen

  • Service de Génétique Médicale, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.
  • Centre de Référence Maladies Rares «Neurogénétique», Service de Génétique Médicale, CHU Bordeaux, Bordeaux, France.
  • University of Bordeaux, CNRS, INCIA, UMR 5287, NRGen Team, Bordeaux, France.
  • MRGM, University of Bordeaux, INSERM U1211, Bordeaux, France.
  • Service d'Anatomie Pathologique, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.
  • Service de Neuroradiologie, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.

ORCID-Profile: Isabelle Coupry

Förderung

  • Agence de la biomédecine

Zitieren

APA

Angelini, C., Durand, C. M., Fergelot, P., Deforges, J., Vital, A., Menegon, P., Sarrazin, E., Bellance, R., Mathis, S., Gonzalez, V., Renaud, M., Frismand, S., Schmitt, E., Rouanet, M., Burglen, L., Chabrol, B., Desnous, B., Arveiler, B., Stevanin, G., …, & Goizet, C. (2023). Autosomal Dominant MPAN : Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes. Movement Disorders, 38(11), 2103-2115. https://doi.org/10.1002/mds.29576

Vancouver

Angelini C, Durand CM, Fergelot P, Deforges J, Vital A, Menegon P, et al. Autosomal Dominant MPAN : Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes. Movement Disorders. 2023;38(11):2103-2115. doi:10.1002/mds.29576

BibTeX
@article{Angelini2023,
  author = {Angelini, Chloé and Durand, Christelle Marie and Fergelot, Patricia and Deforges, Julie and Vital, Anne and Menegon, Patrice and Sarrazin, Elizabeth and Bellance, Rémi and Mathis, Stéphane and Gonzalez, Victoria and Renaud, Mathilde and Frismand, Solène and Schmitt, Emmanuelle and Rouanet, Marie and Burglen, Lydie and Chabrol, Brigitte and Desnous, Béatrice and Arveiler, Benoît and Stevanin, Giovanni and Coupry, Isabelle and Goizet, Cyril},
  title = {Autosomal Dominant MPAN : Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes},
  journal = {Movement Disorders},
  year = {2023},
  volume = {38},
  number = {11},
  pages = {2103--2115},
  doi = {10.1002/mds.29576}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche